Home blood-pressure monitoring in patients receiving sunitinib.
Azizi
Michel
M
Chedid
Antoine
A
Oudard
Stéphane
S
D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects; D001794:Blood Pressure / Q000187:drug effects; D018660:Blood Pressure Monitoring, Ambulatory; D002292:Carcinoma, Renal Cell / Q000188:drug therapy; D006339:Heart Rate / Q000187:drug effects; D006701:Home Nursing; D006801:Humans; D006973:Hypertension / Q000139:chemically induced / Q000175:diagnosis; D007211:Indoles / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy; D011758:Pyrroles / Q000009:adverse effects*; D020794:Receptor Protein-Tyrosine Kinases; D000077210:Sunitinib; D017216:Telemedicine
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D020794:Receptor Protein-Tyrosine Kinases; D000077210:Sunitinib